Perinatal asphyxia from the obstetric standpoint.


Journal

Seminars in fetal & neonatal medicine
ISSN: 1878-0946
Titre abrégé: Semin Fetal Neonatal Med
Pays: Netherlands
ID NLM: 101240003

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 28 6 2021
medline: 18 3 2022
entrez: 27 6 2021
Statut: ppublish

Résumé

Perinatal asphyxia remains one of the major causes of morbidity and mortality for term newborns. Though access to health care and birth attendants have decreased the rate, Neonatal encephalopathy (NE) has not been eliminated. Worldwide, women at socioeconomic disadvantage have the highest risk of delivering a neonate with NE. Neonates that will experience perinatal asphyxia cannot be easily identified prospectively and the intrapartum testing available is not specific enough to clearly indicate the best course of action in most cases. Despite this, training programs that aim to decrease morbidity and mortality from all causes appear to be associated with fewer cases of perinatal asphyxia. The current best approach is to support education and communication for all people involved in the care of birthing women. Ideally, new technology will address identification of the fetus likely to be affected or the fetus who is beginning to experience injury in advance of delivery.

Identifiants

pubmed: 34175240
pii: S1744-165X(21)00067-6
doi: 10.1016/j.siny.2021.101259
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101259

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Meghan G Hill (MG)

Department of Obstetrics and Gynaecology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand. Electronic address: meghan.hill@auckland.ac.nz.

Kathryn L Reed (KL)

Department of Obstetrics and Gynecology, University of Arizona College of Medicine Tucson, Tucson, USA. Electronic address: kreed@obgyn.arizona.edu.

Richard N Brown (RN)

Divisions of Obstetrics, Maternal Fetal Medicine and Ultrasound, Department of Obstetrics & Gynaecology, McGill University Health Centre, Montreal, Canada. Electronic address: richard.brown@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH